Blog

ETFs having a tough year after roaring 2014

At this time last year, 66% of ETFs were up. The recent selloff in the biotech sector has also erased names from the leaderboard, and now just seven ETFs have returns above 10% for the year. Last year it was 114 ETFs.

A look at the five best performers so far reveals an eclectic group of small, relatively unknown ETFs with combined assets of just $260 million. The top spot tends to go to a smaller ETF riding a particularly timely trend, though there are more of these eclectic players at the top of the chart this year.

Could one of these faces in the crowd actually wind up as No. 1?

Read More

Please Login to comment.
Statements and opinions expressed in articles, reviews and other materials herein are those of the authors; the editors and publishers.
While every care has been taken in the compilation of this information and every attempt made to present up-to-date and accurate information, we cannot guarantee that inaccuracies will not occur. FundPage, Inc. will not be held responsible for any claim, loss, damage or inconvenience caused as a result of any information within these pages or any information accessed through this site.
The content of any organizations' websites which you link to from www.FundPage.com are entirely out of the control of FundPage, Inc., and you proceed at your own risk. These links are provided purely for your convenience. They do not imply FundPage, Inc.’s endorsement of, or association with any products, services, content, information or materials offered by or accessible to you at the organization’s site.
All copyright and trademarks accessible via the links from www.FundPage.com are owned by the respective website owners, or their licensors.
FundPage shall also have the right to remove any contents posted at any time without cause as FundPage determines in its sole discretion.

My Community

My Friends